Co-delivery of Paclitaxel and Adriamycin on Nanoparticle

Chuanming Jiang; Qiong Wu

doi:10.54254/2755-2721/3/20230341

Research Article

Open access

Published on 25 May 2023

Download pdf

Jiang,C.;Wu,Q. (2023). Co-delivery of Paclitaxel and Adriamycin on Nanoparticle. Applied and Computational Engineering,3,50-57.

Export citation

Co-delivery of Paclitaxel and Adriamycin on Nanoparticle

Chuanming Jiang *^,1, Qiong Wu ²

¹ Chemical and Biomolecular School, USYD, Sydney, 2006, Australia
² School of Beijing New Talent Academy, Beijing,100000, China

* Author to whom correspondence should be addressed.

https://doi.org/10.54254/2755-2721/3/20230341

Abstract

Based on the threat of cancer to human life and the surge in breast cancer prevalence and mortality in recent years, existing drugs and treatments remain harmful and have side effects. A nano-drug delivery platform is proposed to achieve precise drug delivery in time and space aspects. Two anti-cancer drugs were encapsulated in a nanoplatform and the synergistic effect of these two drugs was utilized to reduce the toxicity of a single drug in conventional chemotherapy and to improve the accuracy of drug delivery. Also, in-vitro and in-vivo experiments of this nanoplatform were designed, and data were collected and analysed to demonstrate the feasibility and future development prospects.

Keywords

PLGA, Paclitaxel, Adriamycin.

View pdf

References

[1]. Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D.M., Piñeros, M., Znaor, A. and Bray, F. (2021). Cancer statistics for the year 2020: an overview. International Journal of Cancer, 149(4). doi:10.1002/ijc.33588.

[2]. www.iarc.who.int. (n.d.). Breast Cancer Awareness Month 2021 – IARC. [online] Available at: https://www.iarc.who.int/featured-news/breast-cancer-awareness-month-2021/.

[3]. PRESS RELEASE N° 292. (2020). [online] Available at: https://www.iarc.who.int/wp-content/uploads/2020/12/pr292_E.pdf.

[4]. www.iarc.who.int. (n.d.). IARC – INTERNATIONAL AGENCY FOR RESEARCH ON CANCER. [online] Available at: https://www.iarc.who.int/.

[5]. Huang, H., Lou, Z., Zheng, S., Wu, J., Yao, Q., Chen, R., Kou, L. and Chen, D. (2022). Intra-articular drug delivery systems for osteoarthritis therapy: shifting from sustained release to enhancing penetration into cartilage. Drug Delivery, 29(1), pp.767–791. doi:10.1080/10717544.2022.2048130.

[6]. Brigger, I., Dubernet, C. and Couvreur, P. (2012). Nanoparticles in cancer therapy and diagnosis. Advanced Drug Delivery Reviews, 64, pp.24–36. doi:10.1016/j.addr.2012.09.006.

[7]. Makadia, H.K. and Siegel, S.J. (2011). Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier. Polymers, [online] 3(3), pp.1377–1397. doi:10.3390/polym3031377.

[8]. Mir, M., Ahmed, N. and Rehman, A. ur (2017). Recent applications of PLGA based nanostructures in drug delivery. Colloids and Surfaces B: Biointerfaces, 159, pp.217–231. doi:10.1016/j.colsurfb.2017.07.038.

[9]. Wang, H., Zhao, Y., Wu, Y., Hu, Y., Nan, K., Nie, G. and Chen, H. (2011). Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Biomaterials, 32(32), pp.8281–8290. doi:10.1016/j.biomaterials.2011.07.032.

[10]. Lv, S., Tang, Z., Li, M., Lin, J., Song, W., Liu, H., Huang, Y., Zhang, Y. and Chen, X. (2014). Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer. Biomaterials, 35(23), pp.6118–6129. doi:10.1016/j.biomaterials.2014.04.034.

Cite this article

Jiang,C.;Wu,Q. (2023). Co-delivery of Paclitaxel and Adriamycin on Nanoparticle. Applied and Computational Engineering,3,50-57.

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

Disclaimer/Publisher's Note

The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

About volume

Volume title: Proceedings of the 3rd International Conference on Materials Chemistry and Environmental Engineering (CONF-MCEE 2023)

Conference website: https://www.confmcee.org/

ISBN：978-1-915371-51-5(Print) / 978-1-915371-52-2(Online)

Conference date: 18 March 2023

Editor：Ioannis Spanopoulos, Sajjad Seifi Mofarah, Niaz Ahmed

Series: Applied and Computational Engineering

Volume number: Vol.3

ISSN：2755-2721(Print) / 2755-273X(Online)

© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open access policy for details).